logo
logo

Korro Bio Closes $91.5 Million Series A Financing to Advance the Next Frontier in RNA Therapeutics

Korro Bio Closes $91.5 Million Series A Financing to Advance the Next Frontier in RNA Therapeutics

09/10/20, 11:08 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgcambridge
Money raised
$91 million
Round Type
series a
Korro Bio, Inc. today announced a $91.5 million Series A financing to advance its novel platform for precise, single-base, RNA editing to modulate protein function for therapeutic applications. This financing enables Korro to advance its lead program to IND filing and establish a broad portfolio of innovative RNA editing therapies.

Company Info

Company
Korro Bio
Location
cambridge, maryland, united states
Additional Info
Korro Bio is creating transformative therapeutics for patients by selectively editing messenger RNA to recode specific codons to deliver a beneficial change in protein sequence, structure, and function.